Skip to content

The Effect of Repetitive Transcranial Magnetic Stimulation on Functional Outcome in Acute Ischemic Stroke Patients

The Effect of Repetitive Transcranial Magnetic Stimulation on Functional Outcome in Acute Ischemic Stroke Patients

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092636
Enrollment
Unknown
Registered
2024-11-20
Start date
2024-11-10
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke

Interventions

rTMS group :Subjects received treatment with repetitive transcranial magnetic stimulation (rTMS).
Pseudo-stimulus group :Stimulation is given to the 8-shaped pseudo-stimulation coil

Sponsors

Department of Neurology, First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.The patient must be 18 years of age or older. 2.Clinical presentation includes focal neurological deficits. Hemorrhagic stroke has been excluded via head CT, and acute ischemic stroke has been confirmed through subsequent head MRI. 3.Patients were randomly assigned to two groups between two to seven days post-stroke, with persistent focal neurological deficits observed in the randomized group. 4.Participants must voluntarily provide signed informed consent.

Exclusion criteria

Exclusion criteria: 1.A history of cognitive impairment or depression. 2.A previous stroke. 3.Inability to complete follow-up assessments. 4.Presence of other life-threatening conditions, such as advanced cancer with a life expectancy of less than six months. 5.Contraindications for rTMS treatment. 6.Incapacity to cooperate with assessments due to consciousness disturbances or severe aphasia. 7.Presence of coronary stents, pacemakers, or other metallic implants in the body. 8.Current or recent (within the last month) receipt of rTMS treatment.

Design outcomes

Primary

MeasureTime frame
Depressive mood;Sleep quality;anxiety state;

Secondary

MeasureTime frame
cognitive ability;Stroke severity;Cardiovascular and cerebrovascular events;

Countries

China

Contacts

Public ContactJun Mu

Department of Neurology, First Affiliated Hospital of Chongqing Medical University

mujun0719@yahoo.com+86 150 2547 2128

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026